VivoSeq
Psychiatry

Cannabis Use

3

Pipeline Programs↗

11

Active Trials↗

2

Companies Involved↗

Cannabis Use is an early-stage landscape with 3 programs across 2 companies. The most active players are TO Pharmaceuticals, Eli Lilly. 1 therapy is approved.

Intelligence

Pipeline Metrics

Competitive Density

34/100

Pipeline Velocity

25/100

Mech. Concentration

100/100

Completion Rate

73/100

Attrition Rate

9/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

T

TO Pharmaceuticals

1 program

Phase 1Eli Lilly logo

Eli Lilly

1 program

Approved

Pipeline

Programs by Phase

Preclinical
No programs
Phase 12

Cannabis

TO Pharmaceuticals

Tobacco Cigarette

Hannah Harris

Phase 2
No programs
Phase 3
No programs
Approved1

Tirzepatide

Eli Lilly

Analysis

Modality Breakdown

2programs
Small molecule150%
Peptide150%

Modality classified for 67% of 3 pipeline programs.

Analysis

Trial Status

22

clinical trials

Completed8 · 36%
Recruiting8 · 36%
Not yet recruiting3 · 14%
Terminated2 · 9%
Suspended1 · 5%

Clinical Trials

Trial Activity

22 trials

Guanfacine Extended-release for Adolescents With Cannabis Use
Recruiting·OOrygen·Phase 2·NCT05957848·100 enrolled
Pilot-Study for the Comparison of Biomarkers Between Regular Cannabis Users and Non-Users
Recruiting·UUniversity of Basel·N/A·NCT06975020·120 enrolled
Cannabidiol and Older Adult Cannabis Users
Recruiting·UUniversity of Colorado, Boulder·Phase 2·NCT06290063·385 enrolled
A Study of Cannabidiol in Young Adult Cannabis Users
Recruiting·UUniversity of Colorado, Denver·Phase 2·NCT06569394·200 enrolled
The Efficacy of a Smart Phone-based Test on Measuring Pupillary Light Reflex Alterations Following Cannabis Use Healthy in Adults
Recruiting·SSobereye Inc.·N/A·NCT06967051·20 enrolled
SCORE Emerging Adult Cannabis Use & Stress
Recruiting·MMedical University of South Carolina·Phase 1/2·NCT05885542·148 enrolled
Oral Fluid Testing to Assess Cannabis Non-Use in Remote Clinical Trials
Recruiting·BBoston Children's Hospital·N/A·NCT06891235·200 enrolled
Neuroimaging of Instrumental Learning Networks in Adolescent Cannabis Use Treatment
Recruiting·IIndiana University·Preclinical·NCT07340554·80 enrolled
A Study of Inhaled Cannabidiol in Healthy Occasional Cannabis Users
Not yet recruiting·—·Phase 1/2·NCT05320367·80 enrolled
Lung Health and Breath Biomarkers: Acute Effects of Combusted and Vaporized Cannabis Inhalation Compared to Tobacco Cigarette Combustion in the Human Laboratory
Not yet recruiting·—·Phase 1·NCT07694466·12 enrolled
A 12-Week Phase 3 Clinical Trial to Evaluate the Safety, Tolerability and Efficacy of Tirzepatide-Assisted-Psychotherapy in Adults With Cannabis Use Disorder: A Proof-of-Concept Study
Not yet recruiting·MMcMaster University·Phase 3·NCT07671248·15 enrolled
Cannabidiol: a Novel Intervention for Cannabis Use Problems?
Completed·UUniversity College, London·Phase 2·NCT02044809·82 enrolled
Reducing the Harmful Effects of Cannabis Use: Finding the Optimal CBD:THC Ratio
Completed·KKing's College London·N/A·NCT05170217·46 enrolled
Fixed or Self-Titrated Dosages of Sativex on Cannabis Users
Completed·CCentre for Addiction and Mental Health·N/A·NCT01748799·16 enrolled
Impact of Progesterone on Stress Reactivity and Cannabis Use
Completed·MMedical University of South Carolina·Phase 2·NCT03729869·148 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)